Home › Liver Cancer (Hepatocellular Carcinoma) › Colorado › Aurora
Liver Cancer (Hepatocellular Carcinoma) clinical trials in Aurora, CO
6 studies for Liver Cancer (Hepatocellular Carcinoma) are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Hospital Colorado, Aurora
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- University of Colorado, Aurora
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Recruiting
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
RecruitingPhase 1/2
- University of Colorado Hospital - Anschutz Medical Campus, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RecruitingPhase 1/2
- University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Aurora
Liver Cancer (Hepatocellular Carcinoma) trials in other cities
- Houston, TX31 studies
- New York City, NY24 studies
- Dallas, TX19 studies
- Los Angeles, CA19 studies
- Boston, MA18 studies
- Cleveland, OH18 studies
- Philadelphia, PA16 studies
- Chicago, IL16 studies
- Pittsburgh, PA15 studies
- San Francisco, CA14 studies
- Orange, CA14 studies
- Jacksonville, FL14 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer31 studies
- Breast Cancer28 studies
- Ovarian Cancer25 studies
- Metastatic Cancer25 studies
- Type 1 Diabetes23 studies
- Obesity22 studies
- Prostate Cancer19 studies
- Lung Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.